BVH-A2 and BVH-A3 antigens of group B
Group B streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
1. An isolated polypeptide comprising
an amino acid sequence at least 95% identical to the amino acid sequence set forth in either SEQ ID NO:7 or SEQ ID NO:8,
wherein the isolated polypeptide is capable of raising antibodies that specifically bind to a polypeptide comprising the amino acid sequence set forth in either SEQ ID NO:7 or SEQ ID NO:8.
2. An isolated polypeptide comprising:
(a) the amino acid sequence set forth in SEQ ID NO:7;
(b) the amino acid sequence set forth in SEQ ID NO: 8;
(c) the polypeptide of (a), wherein the N-terminal methionine residue is deleted; or
(d) the polypeptide of (a), wherein the signal peptide amino acid sequence is deleted.
3. A chimeric polypeptide comprising two or more polypeptides wherein each of the two or more polypeptides comprises at least twenty contiguous amino acids of the amino acid set forth in SEQ ID NO:8, and wherein the two or more polypeptides are linked as to form a chimeric polypeptide.
4. A chimeric polypeptide comprising two or more polypeptides wherein each of the two or more polypeptides comprises a sequence chosen from SEQ ID NOS: 7 and 8, and wherein the two or more polypeptides are linked as to form a chimeric polypeptide.
5. A pharmaceutical composition comprising a polypeptide according to claim 1 or claim 2 and a pharmaceutically acceptable carrier, diluent or adjuvant.
6. A kit comprising the polypeptide according to either claim 1 or claim 2 for detection or diagnosis of a group B Streptococcus infection.
7. An isolated polypeptide comprising a fragment that comprises at least twenty contiguous amino acids of the amino acid sequence set forth in SEQ ID NO:8,
wherein the isolated polypeptide is capable of raising antibodies that specifically bind to a polypeptide comprising the amino acid sequence set forth in either SEQ ID NO:7 or SEQ ID NO:8.
8. A pharmaceutical composition comprising the polypeptide according to claim 7 and a pharmaceutically acceptable carrier, diluent, or adjuvant.